Masoud H Manjili
Overview
Explore the profile of Masoud H Manjili including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
116
Citations
4235
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Koelsch N, Mirshahi F, Aqbi H, Saneshaw M, Seneshaw M, Idowu M, et al.
bioRxiv
. 2024 Jun;
PMID: 38903113
Background: Metabolic dysfunction-associated fatty liver disease (MAFLD) can progress to hepatocellular carcinoma (HCC), yet the immune mechanisms driving this transition remain unclear. Methods: In a chronic Western diet (WD) mouse...
3.
Floros K, Fairchild Jr C, Li J, Zhang K, Roberts J, Kurupi R, et al.
Res Sq
. 2024 Jun;
PMID: 38883782
Synovial Sarcoma (SS) is driven by the SS18::SSX fusion oncoprotein and is ultimately refractory to therapeutic approaches. SS18::SSX alters ATP-dependent chromatin remodeling BAF (mammalian SWI/SNF) complexes, leading to the degradation...
4.
Manjili M, Manjili S
Scand J Immunol
. 2024 May;
100(2):e13375.
PMID: 38750629
Our understanding of the immune response is far from complete, missing out on more detailed explanations that could be provided by molecular insights. To bridge this gap, we introduce the...
5.
Floros K, Fairchild C, Li J, Zhang K, Roberts J, Kurupi R, et al.
bioRxiv
. 2024 May;
PMID: 38712286
Synovial Sarcoma (SS) is driven by the SS18::SSX fusion oncoprotein. and is ultimately refractory to therapeutic approaches. SS18::SSX alters ATP-dependent chromatin remodeling BAF (mammalian SWI/SNF) complexes, leading to the degradation...
6.
Koelsch N, Manjili M
Int J Mol Sci
. 2023 Aug;
24(15).
PMID: 37569461
The tumor microenvironment (TME) is a complex and dynamic ecosystem that includes a variety of immune cells mutually interacting with tumor cells, structural/stromal cells, and each other. The immune cells...
7.
Koelsch N, Mirshahi F, Aqbi H, Saneshaw M, Idowu M, Olex A, et al.
Sci Rep
. 2023 Aug;
13(1):12630.
PMID: 37537225
Abundance of data on the role of inflammatory immune responses in the progression or inhibition of hepatocellular carcinoma (HCC) has failed to offer a curative immunotherapy for HCC. This is...
8.
Manjili M
J Immunol
. 2023 Mar;
210(5):521-530.
PMID: 36881868
Current research in immunology and immunotherapy is fully influenced by the self-nonself model of immunity. This theoretical model suggests that alloreactivity results in graft rejection, whereas tolerance toward self-antigens expressed...
9.
Qian J, Yu X, Liu Z, Cai J, Manjili M, Yang H, et al.
Front Immunol
. 2023 Feb;
14:1118781.
PMID: 36793731
We have previously demonstrated that scavenger receptor A (SRA) acts as an immunosuppressive regulator of dendritic cell (DC) function in activating antitumor T cells. Here we investigate the potential of...
10.
Manjili M
Scand J Immunol
. 2023 Jan;
97(4):e13255.
PMID: 36680379
Current research and drug development for multiple sclerosis (MS) is fully influenced by the self-nonself (SNS) model of immunity, suggesting that breakage of immunological tolerance towards self-antigens expressed in the...